scispace - formally typeset
K

Karen Rokkedal Lausch

Researcher at Statens Serum Institut

Publications -  6
Citations -  667

Karen Rokkedal Lausch is an academic researcher from Statens Serum Institut. The author has contributed to research in topics: Infant mortality & Vitamin. The author has an hindex of 4, co-authored 5 publications receiving 571 citations. Previous affiliations of Karen Rokkedal Lausch include Bandim Health Project.

Papers
More filters
Journal ArticleDOI

Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial.

TL;DR: The combined results of this trial and the complementary trial among normal birthweight neonates have now shown that, overall, it would not be beneficial to implement a neonatal vitamin A supplementation policy in Guinea-Bissau.
Journal ArticleDOI

Early diphtheria-tetanus-pertussis vaccination associated with higher female mortality and no difference in male mortality in a cohort of low birthweight children: an observational study within a randomised trial

TL;DR: Even though the children with the best nutritional status were vaccinated early, early DTP vaccination was associated with increased mortality for girls, and small mid-upper arm circumference was the strongest predictor of mortality.
Journal ArticleDOI

Two different doses of supplemental vitamin A did not affect mortality of normal-birth-weight neonates in Guinea-Bissau in a randomized controlled trial

TL;DR: It is observed that a smaller dose of vitamin A may decrease mortality more than a larger dose and conducted a randomized, double-blind, placebo-controlled trial in Guinea-Bissau with the primary aim of comparing the effect of 50,000 with 25,000 IU neonatal vitamin A on infant mortality.

Two Different Doses of Supplemental Vitamin A Did Not Affect Mortality of Normal-Birth-Weight Neonates in Guinea-Bissau in a Randomized

TL;DR: A randomized, double-blind, placebo-controlled trial was conducted in Guinea-Bissau with the primary aim of comparing the effect of 50,000 with 25,000 IU neonatal vitamin A on infant mortality as discussed by the authors.